- Home
- SN vs QGEN Comparison
SN vs QGEN Comparison
Compare SN & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SN | QGEN |
|---|---|---|
| Founded | 1993 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 10.7B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | SN | QGEN |
|---|---|---|
| Price | $101.20 | $47.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $126.29 | $50.68 |
| AVG Volume (30 Days) | ★ 2.3M | 1.3M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 3.19% |
| EPS Growth | 58.74 | ★ 331.20 |
| EPS | ★ 4.05 | 1.84 |
| Revenue | ★ $6,084,941,000.00 | $2,070,781,000.00 |
| Revenue This Year | $18.26 | $7.37 |
| Revenue Next Year | $11.75 | $5.65 |
| P/E Ratio | ★ $25.03 | $25.97 |
| Revenue Growth | ★ 18.87 | 5.32 |
| 52 Week Low | $60.50 | $37.63 |
| 52 Week High | $128.51 | $51.88 |
Technical Indicators
Market Signals| Indicator | SN | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 64.21 | 57.35 |
| Support Level | $83.21 | $43.59 |
| Resistance Level | $90.53 | $48.69 |
| Average True Range (ATR) | 4.20 | 0.75 |
| MACD | 1.75 | 0.44 |
| Stochastic Oscillator | 96.49 | 73.26 |
Price Performance
Historical ComparisonAbout SN SharkNinja Inc.
SharkNinja Inc is a product design and technology company that creates 5-star-rated lifestyle solutions through inventive products for consumers around the world. Its product categories include Cleaning, Cooking, Food Preparation, Home Environment and Beauty products. It sells vacuum cleaners, cooking pots, fryers, hair dryers, etc. The SharkNinja Group is expected to carry on the design, production, marketing, and distribution of the Shark and Ninja brands of small household appliances in North America, Europe and other selected international markets (excluding the Asia Pacific Region and Greater China). Currently, the majority of the revenue is derived from the U.S. market.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).